» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome > Name & Property Search
Search results for 'Idenix Pharmaceuticals' | Search again
DeSoto Public Records:0
Shelby Public Records:0
Editorial:2
West Tennessee:0
Middle Tennessee:0
East Tennessee:0
Other:0

You must be a subscriber to see the full results of your search.

Please log in or subscribe below if you are not already a subscriber.

The Daily News subscribers get full access to more than 13 million names and addresses along with powerful search and download features. Get the business leads you need with powerful searches of public records and notices. Download listings into your spreadsheet or database.

Learn more about our services | Search again


Editorial Results (free)

1. Merck to Pay $3.85 Billion for Hepatitis C Drug Developer -

TRENTON, N.J. (AP) – Merck & Co. will spend about $3.85 billion for Idenix Pharmaceuticals Inc., a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies that quickly cure most patients with the blood-borne virus afflicting tens of millions.

2. Report: Glaxo in Talks to Buy Indian Generic Maker -

NEW YORK (AP) - U.K. drug developer GlaxoSmithKline PLC is reportedly in talks to buy Indian generic drug developer Piramal Healthcare Ltd. for about $1.5 billion.

Late Friday, the Wall Street Journal reported that people familiar with the potential deal said the companies are at an early stage of talks. GlaxoSmithKline said it would not comment, and Piramal could not be reached for comment.